Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-rhPSMA-7.3 PET-mpMR for Prostate Biopsy Targeting
NCT06865768Phase 2Recruiting
- Sponsor
- Emory University
- Start
- Apr 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of flotufolastat f 18 in prostate cancer (PCa), sponsored by Emory University. Started Apr 2025; status: recruiting.
02
Drugs
flotufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06865768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06865768.